MycoMedica Life Sciences, PBC develops fungi-based therapeutic drugs for psychiatric and neurological disorders.
MycoMedica Life Sciences, PBC has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
MycoMedica Life Sciences, PBC's investors include True Ventures, Obvious Ventures, Artis Ventures, KittyHawk, Zen Chu.
MycoMedica Life Sciences, PBC is headquartered in Shelton, United States.
MycoMedica Life Sciences, PBC develops fungi-based therapeutic drugs for psychiatric and neurological disorders.
MycoMedica Life Sciences, PBC is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MycoMedica Life Sciences, PBC — Funding & Investors." VCBacked, June 1, 2022, https://www.vcbacked.co/company/mycomedica-life-sciences-pbc. Accessed September 29, 2026.
VCBacked. (2022). MycoMedica Life Sciences, PBC — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/mycomedica-life-sciences-pbc
{{cite web |title=MycoMedica Life Sciences, PBC — Funding & Investors |url=https://www.vcbacked.co/company/mycomedica-life-sciences-pbc |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated